Recent recalls of dozens of lots of the front-line blood pressure and heart medications including valsartan, losartan, and irbesartan are placing the spotlight on impurities in generic drugs. After inspections of certain factories in China, Slovenia, and India, the FDA found that the recalled drugs contained cancer-causing impurities. Impurities are defined as substances inside a […]
The post Best Practices to Reduce Impurities in Generics appeared first on The Weinberg Group.